ArticleHarm reduction journal2026
Drug checking services: barriers and facilitators to implementation by U.S. syringe services programs.
Article in Harm reduction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSyringe services programs (SSPs) provide evidence-based services to prevent the spread of disease and reduce overdose mortality among people who use drugs. To address unacceptably high levels of overdose, some SSPs have implemented advanced drug checking services (DCS) to identify illicitly manufactured fentanyl, xylazine, and other unexpected substances in local drug supplies. Advanced DCS improve people's knowledge of the illicit drug market and can support widescale dissemination of information for monitoring and evaluation of drug supply trends.
objectiveTo investigate the barriers and facilitators to implementing advanced DCS at SSPs across the United States.
methodsWe conducted semi-structured interviews between May 31st and July 2nd 2023 with 23 SSP representatives in the United States. We used purposive sampling methods to include programs covering a variety of perspectives and experiences, varying by region, program type, and legal status. We used a deductive analytic approach to code transcripts and met weekly to refine codes and capture emerging themes. After identifying barriers and facilitators as key themes, we further coded the data using domains and constructs from the Consolidated Framework for Implementation Research.
resultsEight of 23 SSPs provided advanced DCS. Most of these collaborated with external partners that hosted and maintained drug checking equipment, analyzed samples, and provided results. Five of these SSPs partnered with laboratories that offered mail-based services-through which participants could mail in their sample, and results would be sent back to SSPs for dissemination. The cost of machines and limited organizational capacity (e.g., staff, physical space) were key reasons that programs required partnerships to provide advanced DCS. Similarly, SSPs that were interested in but had not implemented advanced DCS noted cost and organizational capacity as primary barriers. Supportive laws and buy-in from law enforcement also impacted the implementation of advanced DCS.
conclusionThe cost and organizational barriers SSPs face implementing advanced DCS can be addressed through collaboration with well-resourced partners. Advanced DCS through SSPs may first require supportive laws and law enforcement buy-in. Additional research on partnerships and other implementation strategies to support advanced DCS may provide a useful roadmap for SSPs interested in offering these services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.